Hiroaki Hattori

3.4k total citations
86 papers, 2.7k citations indexed

About

Hiroaki Hattori is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Hiroaki Hattori has authored 86 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 27 papers in Endocrinology, Diabetes and Metabolism and 24 papers in Molecular Biology. Recurrent topics in Hiroaki Hattori's work include Lipoproteins and Cardiovascular Health (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Cancer, Lipids, and Metabolism (19 papers). Hiroaki Hattori is often cited by papers focused on Lipoproteins and Cardiovascular Health (26 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers) and Cancer, Lipids, and Metabolism (19 papers). Hiroaki Hattori collaborates with scholars based in Japan, Netherlands and United Kingdom. Hiroaki Hattori's co-authors include Tadao Iwasaki, Yoshinori Nozawa, Takeshi Kujiraoka, Mitsuaki Ishihara, Tohru Egashira, Sadao Takahashi, N.E. Miller, Toyohiko Tohmatsu, Shigeru Nakashima and Makoto Nagano and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Hiroaki Hattori

85 papers receiving 2.6k citations

Peers

Hiroaki Hattori
David W. Garber United States
Hiroaki Hattori
Citations per year, relative to Hiroaki Hattori Hiroaki Hattori (= 1×) peers David W. Garber

Countries citing papers authored by Hiroaki Hattori

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Hattori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Hattori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Hattori more than expected).

Fields of papers citing papers by Hiroaki Hattori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Hattori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Hattori. The network helps show where Hiroaki Hattori may publish in the future.

Co-authorship network of co-authors of Hiroaki Hattori

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Hattori. A scholar is included among the top collaborators of Hiroaki Hattori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Hattori. Hiroaki Hattori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashida, Tetsu, Hiromitsu Jinno, Hiroki Sato, et al.. (2018). Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial. BMC Cancer. 18(1). 701–701. 13 indexed citations
2.
Takahashi, Sadao, Takashi Ito, Yasuo Zenimaru, et al.. (2011). Species differences of macrophage very low-density-lipoprotein (VLDL) receptor protein expression. Biochemical and Biophysical Research Communications. 407(4). 656–662. 20 indexed citations
3.
Karalis, Ioannis, Sandrin C. Bergheanu, Ron Wolterbeek, et al.. (2010). Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters. Current Medical Research and Opinion. 26(10). 2301–2313. 23 indexed citations
4.
Kato, Yutaro, Kentaro Matsubara, Yoshinobu Akiyama, et al.. (2010). Direct biliopancreatoduodenal invasion by hepatocellular carcinoma: report of the first resected case and review of the literature. International Journal of Clinical Oncology. 16(4). 421–427. 6 indexed citations
5.
Kato, Yutaro, Kentaro Matsubara, Yoshinobu Akiyama, et al.. (2009). Chemotherapy-induced sclerosing cholangitis as a rare indication for resection: Report of a case. Surgery Today. 39(10). 905–908. 4 indexed citations
6.
Akiyama, Yoshinobu, et al.. (2008). A Case of Spontaneous Isolated Dissection of the Superior Mesenteric Artey. The Japanese Journal of Gastroenterological Surgery. 41(8). 1619–1624. 3 indexed citations
7.
Schaap, Frank G., Melchior C. Nierman, Jimmy F.P. Berbée, et al.. (2006). Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia. Journal of Lipid Research. 47(10). 2333–2339. 46 indexed citations
8.
Henneman, Peter, Frank G. Schaap, Louis M. Havekes, et al.. (2006). Plasma apoAV levels are markedly elevated in severe hypertriglyceridemia and positively correlated with the APOA5 S19W polymorphism. Atherosclerosis. 193(1). 129–134. 59 indexed citations
9.
Arai, Hidenori, Akira Yamamoto, Yūji Matsuzawa, et al.. (2005). Polymorphisms in Four Genes Related to Triglyceride and HDL-cholesterol Levels in the General Japanese Population in 2000. Journal of Atherosclerosis and Thrombosis. 12(5). 240–250. 37 indexed citations
10.
Takahashi, Yoshitaka, Hong Zhu, Takashi Murakami, et al.. (2005). Selective uptake and efflux of cholesteryl linoleate in LDL by macrophages expressing 12/15-lipoxygenase. Biochemical and Biophysical Research Communications. 338(1). 128–135. 21 indexed citations
11.
Iwasaki, Tadao, Sadao Takahashi, Masao Takahashi, et al.. (2005). Deficiency of the Very Low-Density Lipoprotein (VLDL) Receptors in Streptozotocin-Induced Diabetic Rats: Insulin Dependency of the VLDL Receptor. Endocrinology. 146(8). 3286–3294. 20 indexed citations
12.
Motoi, Yumiko, Hideo Mori, Yoshikuni Mizuno, et al.. (2004). Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice. Neuroscience Letters. 368(2). 144–147. 16 indexed citations
13.
Iwasaki, Tadao, Sadao Takahashi, Mitsuaki Ishihara, et al.. (2004). The important role for βVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor. Journal of Human Genetics. 49(11). 622–628. 4 indexed citations
14.
Kujiraoka, Takeshi, Hiroaki Hattori, Mayumi Ito, et al.. (2004). Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid. Atherosclerosis. 176(1). 57–62. 8 indexed citations
15.
Zhu, Hong, Yoshitaka Takahashi, Takashi Murakami, et al.. (2003). Low Density Lipoprotein Receptor-related Protein-mediated Membrane Translocation of 12/15-Lipoxygenase Is Required for Oxidation of Low Density Lipoprotein by Macrophages. Journal of Biological Chemistry. 278(15). 13350–13355. 50 indexed citations
16.
Takahashi, Yoshitaka, et al.. (2001). Low Density Lipoprotein Receptor-related Protein Is Required for Macrophage-mediated Oxidation of Low Density Lipoprotein by 12/15-Lipoxygenase. Journal of Biological Chemistry. 276(39). 36454–36459. 29 indexed citations
17.
T, Oka, Takeshi Kujiraoka, Mayumi Ito, et al.. (2000). Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. Journal of Lipid Research. 41(10). 1651–1657. 89 indexed citations
18.
Matsumoto, Shuji, et al.. (1992). AT-4526, A New Quinolone Derivative. American Association of Bovine Practitioners Conference Proceedings. 192–198. 1 indexed citations
19.
Tohmatsu, Toyohiko, et al.. (1987). A role of diacylglycerol kinase in stimulus-secretion coupling of human platelets dissociation of serotonin secretion from ca2+ mobilization. Thrombosis Research. 47(1). 25–35. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026